Alvotech (ALVO) stock
ALVONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ALVOW
$4.55+0.18 (+4.12%)
Close on Nov 18, 2026Market cap $1.42BP/E 45.5Yield –
Alvotech price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Alvotech's price to sales ratio was 3.0× on Nov 11, 2026, against 3.2× a year earlier. Over the last 5 years it ranged from 0.1× to 95.0×, with a median of 5.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.0× | −0.3 |
| 2025 | Dec 31, 2025 | 3.3× | −37.2 |
| 2024 | Dec 31, 2024 | 40.4× | +3.6 |
| 2023 | Dec 29, 2023 | 36.8× | +36.5 |
| 2022 | Dec 30, 2022 | 0.2× | −13.6 |
| 2021 | Dec 31, 2021 | 13.9× | – |
See a number that looks wrong?